These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28371856)

  • 1. Population Modeling of Modified Risk Tobacco Products Accounting for Smoking Reduction and Gradual Transitions of Relative Risk.
    Poland B; Teischinger F
    Nicotine Tob Res; 2017 Nov; 19(11):1277-1283. PubMed ID: 28371856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
    Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
    Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.
    Wackowski OA; O'Connor RJ; Pearson JL
    Nicotine Tob Res; 2021 Feb; 23(3):605-608. PubMed ID: 32812028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14).
    Pearson JL; Johnson AL; Johnson SE; Stanton CA; Villanti AC; Niaura RS; Glasser AM; Wang B; Abrams DB; Cummings KM; Hyland A
    Addiction; 2018 Jan; 113(1):113-124. PubMed ID: 28734111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to assess the population health impact of introducing a Modified Risk Tobacco Product.
    Weitkunat R; Lee PN; Baker G; Sponsiello-Wang Z; González-Zuloeta Ladd AM; Lüdicke F
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):87-93. PubMed ID: 25819932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity.
    Valentine GW; Hefner K; Jatlow PI; Rosenheck RA; Gueorguieva R; Sofuoglu M
    J Dual Diagn; 2018; 14(1):2-13. PubMed ID: 29083287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product.
    Max WB; Sung HY; Lightwood J; Wang Y; Yao T
    Tob Control; 2018 Nov; 27(Suppl 1):s82-s86. PubMed ID: 30275170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.
    Lee PN; Abrams D; Bachand A; Baker G; Black R; Camacho O; Curtin G; Djurdjevic S; Hill A; Mendez D; Muhammad-Kah RS; Murillo JL; Niaura R; Pithawalla YB; Poland B; Sulsky S; Wei L; Weitkunat R
    Nicotine Tob Res; 2021 Feb; 23(3):426-437. PubMed ID: 32496514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Modified Risk Tobacco Product Claims on Consumer Responses.
    Seidenberg AB; Boynton MH; Brewer NT; Lazard AJ; Sheeran P; Ribisl KM
    Nicotine Tob Res; 2024 Mar; 26(4):435-443. PubMed ID: 37791605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a hypothetical modified risk tobacco product claim on heated tobacco product use intention and perceptions in young adults.
    Chen-Sankey JC; Kechter A; Barrington-Trimis J; McConnell R; Krueger EA; Cruz TB; Unger JB; Chaffee BW; Leventhal A
    Tob Control; 2023 Jan; 32(1):42-50. PubMed ID: 34059552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Nicotine Dependence in E-Cigarettes' Potential for Smoking Reduction.
    Selya AS; Dierker L; Rose JS; Hedeker D; Mermelstein RJ
    Nicotine Tob Res; 2018 Sep; 20(10):1272-1277. PubMed ID: 29065204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette.
    Murphy J; Gaca M; Lowe F; Minet E; Breheny D; Prasad K; Camacho O; Fearon IM; Liu C; Wright C; McAdam K; Proctor C
    Regul Toxicol Pharmacol; 2017 Nov; 90():342-357. PubMed ID: 28954704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis.
    Kalkhoran S; Glantz SA
    JAMA Intern Med; 2015 Oct; 175(10):1671-80. PubMed ID: 26322924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of E-cigarette Use and Subsequent Cigarette Smoking Cessation Over 2 Years (2013/2014-2015/2016) in the Population Assessment of Tobacco and Health Study.
    Glasser AM; Vojjala M; Cantrell J; Levy DT; Giovenco DP; Abrams D; Niaura R
    Nicotine Tob Res; 2021 Mar; 23(4):669-677. PubMed ID: 32939555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the risk-reduction potential of new Modified Risk Tobacco Products.
    Martin F; Vuillaume G; Baker G; Sponsiello-Wang Z; Ricci PF; Lüdicke F; Weitkunat R
    Regul Toxicol Pharmacol; 2018 Feb; 92():358-369. PubMed ID: 29258927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to e-cigarette health claims and association with e-cigarette use and risk perceptions: A cohort study of young adults.
    Wagoner KG; Reboussin BA; Ross JC; Denlinger-Apte R; Spangler J; Sutfin EL
    Addict Behav; 2022 Sep; 132():107359. PubMed ID: 35576816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modeling approach to gauging the effects of nicotine vaping product use on cessation from cigarettes: what do we know, what do we need to know?
    Levy DT; Yuan Z; Li Y; Alberg AJ; Cummings KM
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):86-96. PubMed ID: 30548714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cohort study of electronic cigarette use: effectiveness and safety at 24 months.
    Manzoli L; Flacco ME; Ferrante M; La Vecchia C; Siliquini R; Ricciardi W; Marzuillo C; Villari P; Fiore M;
    Tob Control; 2017 May; 26(3):284-292. PubMed ID: 27272748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to Gradual and Immediate Reduction of Nicotine in Cigarettes in Young Versus Older Adult Smokers.
    Cassidy RN; Tidey JW; Cao Q; Colby SM; McClernon FJ; Smith TT; Dermody S; Koopmeiners JS; Jensen JA; Strayer LG; Donny EC; Hatsukami D
    Nicotine Tob Res; 2021 Aug; 23(9):1559-1566. PubMed ID: 33754156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cigarette use and smoking reduction or cessation in the 2010/2011 TUS-CPS longitudinal cohort.
    Shi Y; Pierce JP; White M; Vijayaraghavan M; Compton W; Conway K; Hartman AM; Messer K
    BMC Public Health; 2016 Oct; 16(1):1105. PubMed ID: 27769302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.